FY20 Results presentation
Filed with ASX · · 17 pages · English
ne 2 DISCLAIMER This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is made as to the accuracy, adequacy or reliability of any statement, estimates, opinions or other information contained in the presentation. This presentat
In the deck
Earlier from Nova Eye Medical
- FY 20 Results
- Full Year Statutory Accounts
- Australian Tax Office Class Ruling on Capital Gain
- Acquisition of Molteno Ophthalmology Assets
- Updated Timetable for Capital Return & Dividend Payment
Later from Nova Eye Medical
- Establishment of AlpaRET
- Sales Update
- Half Year Results Discussion
- Investor presentation Half year Results 31 December 2020
- Clinical trial to Assess Efficacy and Safety of i Track
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical